{"id":44577,"date":"2022-06-01T18:01:48","date_gmt":"2022-06-01T16:01:48","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/"},"modified":"2022-06-01T18:01:48","modified_gmt":"2022-06-01T16:01:48","slug":"sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/","title":{"rendered":"Sparrow Pharmaceuticals to Present New Pharmacology Data on SPI-62 at the 2022 Annual European Congress of Rheumatology"},"content":{"rendered":"<div>\n<p>PORTLAND, Ore.&#8211;(BUSINESS WIRE)&#8211;<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.sparrowpharma.com%2F&amp;esheet=52736863&amp;newsitemid=20220601006016&amp;lan=en-US&amp;anchor=Sparrow+Pharmaceuticals%2C&amp;index=1&amp;md5=a458c3b0345dc1bea4f1b48f38e1c0c3\" rel=\"nofollow noopener\" shape=\"rect\">Sparrow Pharmaceuticals,<\/a> an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and rheumatology, today announced that it will present new pharmacology data at the 2022 Annual European Congress of Rheumatology (EULAR) on its lead candidate, SPI-62, an HSD-1 inhibitor. SPI-47, a fixed-dose-combination of SPI-62 and prednisolone, is being developed for autoimmune and inflammatory diseases beginning with polymyalgia rheumatica. Sparrow will present the data during an in-person poster session. EULAR 2022 will take place 1-4 June 2022, at the Bella Center Copenhagen in Copenhagen, Denmark.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220601006016\/en\/1473377\/5\/Sparrow_Logo_RGB_CORE_Horizontal.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220601006016\/en\/1473377\/21\/Sparrow_Logo_RGB_CORE_Horizontal.jpg\"><\/a><\/p>\n<p>\nThe poster presentation details are summarized below:\n<\/p>\n<p>\n<b><span class=\"bwuline\">EULAR 2022 In-Person Poster Presentation<\/span><\/b>\n<\/p>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Title<\/b>: Toward Safer Glucocorticoid Therapy of Polymyalgia Rheumatica\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Poster Number:<\/b> POS1332\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Presenting Author<\/b>: David A. Katz, Ph.D.\n<\/li>\n<\/ul>\n<ul class=\"bwlistdisc\">\n<li>\n<b>Session Date\/Time<\/b>: 4 June, 2022<\/p>\n<ul class=\"bwlistcircle\">\n<li>\nDr. Katz will be in-person with the poster on 4 June at 10:15\u2013 11:00 GMT +2\n<\/li>\n<li>\nThe poster will be displayed on Screen 123 in the EULAR Science Exhibit on 4 June at 8:45 &#8211; 9:30, 10:15\u2013 11:00, 11:45 &#8211; 12:30, and 13:15 &#8211; 13:45 GMT +2\n<\/li>\n<li>\nThe poster and pre-recorded narration will also be available on the EULAR conference app from 1 June until 31 July\n<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p>\nTo register and view the abstracts, visit EULAR\u2019s website <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fcongress.eular.org%2F&amp;esheet=52736863&amp;newsitemid=20220601006016&amp;lan=en-US&amp;anchor=here&amp;index=2&amp;md5=7d9ad15a443ed297a847c790f8b9c3c8\" rel=\"nofollow noopener\" shape=\"rect\">here<\/a>.\n<\/p>\n<p>\nTo learn more about Sparrow Pharmaceuticals and its leadership team, visit the website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.sparrowpharma.com&amp;esheet=52736863&amp;newsitemid=20220601006016&amp;lan=en-US&amp;anchor=www.sparrowpharma.com&amp;index=3&amp;md5=489d932e96ef757aa153e2338b12fb8a\" rel=\"nofollow noopener\" shape=\"rect\">www.sparrowpharma.com<\/a>.\n<\/p>\n<p>\n<b>About Sparrow Pharmaceuticals<\/b>\n<\/p>\n<p>\nSparrow Pharmaceuticals was founded to spare patients the ravages of steroids. Leveraging underappreciated scientific insights into steroid biology, the company is working to provide better treatment options for serious disorders of hypercortisolism, and to revolutionize the treatment of autoimmune and inflammatory conditions.SPI-62, is an oral, small molecule, novel therapeutic treatment designed to target the source of active intracellular glucocorticoids in key tissues. SPI-47 is a fixed-dose-combination of SPI-62 and the glucocorticoid medicine prednisolone.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nAlexis Feinberg<br \/>\n<br \/>ICR Westwicke<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#111;&#58;&#65;&#108;exi&#x73;&#x2e;&#x46;&#x65;&#x69;&#x6e;&#98;&#101;&#114;g&#64;w&#x65;&#x73;&#x74;&#x77;&#x69;&#x63;&#107;&#101;&#46;&#99;om\" rel=\"nofollow noopener\" shape=\"rect\">&#65;l&#x65;x&#x69;s&#x2e;&#70;&#x65;&#105;&#x6e;&#98;e&#x72;g&#x40;w&#x65;&#115;&#x74;&#119;&#x69;&#99;&#x6b;&#101;&#46;&#x63;o&#x6d;<\/a><br \/>203-939-2225\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>PORTLAND, Ore.&#8211;(BUSINESS WIRE)&#8211;Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and rheumatology, today announced that it will present new pharmacology data at the 2022 Annual European Congress of Rheumatology (EULAR) on its lead candidate, SPI-62, an HSD-1 inhibitor. SPI-47, a fixed-dose-combination of SPI-62 and prednisolone, &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44577","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Sparrow Pharmaceuticals to Present New Pharmacology Data on SPI-62 at the 2022 Annual European Congress of Rheumatology - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sparrow Pharmaceuticals to Present New Pharmacology Data on SPI-62 at the 2022 Annual European Congress of Rheumatology - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"PORTLAND, Ore.&#8211;(BUSINESS WIRE)&#8211;Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and rheumatology, today announced that it will present new pharmacology data at the 2022 Annual European Congress of Rheumatology (EULAR) on its lead candidate, SPI-62, an HSD-1 inhibitor. SPI-47, a fixed-dose-combination of SPI-62 and prednisolone, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-06-01T16:01:48+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220601006016\/en\/1473377\/21\/Sparrow_Logo_RGB_CORE_Horizontal.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Sparrow Pharmaceuticals to Present New Pharmacology Data on SPI-62 at the 2022 Annual European Congress of Rheumatology\",\"datePublished\":\"2022-06-01T16:01:48+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\\\/\"},\"wordCount\":308,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220601006016\\\/en\\\/1473377\\\/21\\\/Sparrow_Logo_RGB_CORE_Horizontal.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\\\/\",\"name\":\"Sparrow Pharmaceuticals to Present New Pharmacology Data on SPI-62 at the 2022 Annual European Congress of Rheumatology - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220601006016\\\/en\\\/1473377\\\/21\\\/Sparrow_Logo_RGB_CORE_Horizontal.jpg\",\"datePublished\":\"2022-06-01T16:01:48+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220601006016\\\/en\\\/1473377\\\/21\\\/Sparrow_Logo_RGB_CORE_Horizontal.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220601006016\\\/en\\\/1473377\\\/21\\\/Sparrow_Logo_RGB_CORE_Horizontal.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sparrow Pharmaceuticals to Present New Pharmacology Data on SPI-62 at the 2022 Annual European Congress of Rheumatology\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sparrow Pharmaceuticals to Present New Pharmacology Data on SPI-62 at the 2022 Annual European Congress of Rheumatology - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/","og_locale":"en_US","og_type":"article","og_title":"Sparrow Pharmaceuticals to Present New Pharmacology Data on SPI-62 at the 2022 Annual European Congress of Rheumatology - Pharma Trend","og_description":"PORTLAND, Ore.&#8211;(BUSINESS WIRE)&#8211;Sparrow Pharmaceuticals, an emerging, clinical-stage biopharmaceutical company developing novel, targeted therapies to address unmet needs in both endocrinology and rheumatology, today announced that it will present new pharmacology data at the 2022 Annual European Congress of Rheumatology (EULAR) on its lead candidate, SPI-62, an HSD-1 inhibitor. SPI-47, a fixed-dose-combination of SPI-62 and prednisolone, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/","og_site_name":"Pharma Trend","article_published_time":"2022-06-01T16:01:48+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220601006016\/en\/1473377\/21\/Sparrow_Logo_RGB_CORE_Horizontal.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Sparrow Pharmaceuticals to Present New Pharmacology Data on SPI-62 at the 2022 Annual European Congress of Rheumatology","datePublished":"2022-06-01T16:01:48+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/"},"wordCount":308,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220601006016\/en\/1473377\/21\/Sparrow_Logo_RGB_CORE_Horizontal.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/","url":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/","name":"Sparrow Pharmaceuticals to Present New Pharmacology Data on SPI-62 at the 2022 Annual European Congress of Rheumatology - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220601006016\/en\/1473377\/21\/Sparrow_Logo_RGB_CORE_Horizontal.jpg","datePublished":"2022-06-01T16:01:48+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220601006016\/en\/1473377\/21\/Sparrow_Logo_RGB_CORE_Horizontal.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220601006016\/en\/1473377\/21\/Sparrow_Logo_RGB_CORE_Horizontal.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/sparrow-pharmaceuticals-to-present-new-pharmacology-data-on-spi-62-at-the-2022-annual-european-congress-of-rheumatology\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Sparrow Pharmaceuticals to Present New Pharmacology Data on SPI-62 at the 2022 Annual European Congress of Rheumatology"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44577","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44577"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44577\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44577"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44577"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44577"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}